Clinical Trial Update: Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants

View source ↗

Summary

This clinical trial update reports the real-world effectiveness of nirsevimab against respiratory syncytial virus–related infections and all-cause lower respira…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Nirsevimab (nirsevimab)

Snippet

Sponsor: Han Tongyan | Conditions: RSV Infections, Lower Respiratory Tract Infections | Status: COMPLETED